Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study

Annals of Internal Medicine

Volumn 133, Issue 12, 2000, Pages 951-963

  Amin, S ^a   Zhang, Y ^a   Sawin, C T ^a   Evans, S R ^a   Hannan, M T ^a   Kiel, D P ^a   Wilson, P W F ^a   Felson, D T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LUTEINIZING HORMONE; TESTOSTERONE;

AGED; AGING; ARTICLE; BONE DENSITY; BONE MINERAL; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMUR NECK; HUMAN; HYPOGONADISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

EID: 0034687826     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-12-200012190-00010     Document Type: Article

References (65)

1. The worldwide problem of osteoporosis: Insights afforded by epidemiology
2. The crippling consequences of fractures and their impact on quality of life
3. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
4. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study
5. Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study
6. Epidemiology of osteoporosis
7. Perspective. How many women have osteoporosis?
8. Hip fractures in the elderly: A worldwide projection
9. Hip fractures among the elderly: Factors associated with in-hospital mortality
10. Hip fracture in elderly men: Prognostic factors and outcomes
11. Mortality after all major types of osteoporotic fracture in men and women: An observational study
12. The effect of postmenopausal estrogen therapy on bone density in elderly women
13. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures
14. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
15. Osteoporosis in men
16. Endocrinology of the hypothalamic-pituitary-testicular axis with particular reference to the hormonal control of spermatogenesis
17. Disorders of the testes
18. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism
19. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling
20. Osteoporosis in men: Diagnosis, pathophysiology, and prevention
21. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism
22. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
23. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men
24. Lack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years
25. Bone mineral density and androgen levels in elderly males
26. Lack of association between free testosterone and bone density separate from age in elderly males
27. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens
28. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
29. Androgens and bone
30. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
31. Effect of testosterone and estradiol in a man with aromatase deficiency
32. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
33. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
34. Osteoporosis and decline of gonadal function in the elderly male
35. Endogenous sex stetoids and bone mineral density in older women and men: The Rancho Bernardo Study
36. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
37. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
38. Epidemiologic approaches to heart disease: The Framingham Heart Study
39. Bone mineral density in elderly men and women: Results from the Framingham osteoporosis study
40. Risk factors for osteoporosis in men
41. Risk factors for spinal osteoporosis in men
42. Effects of weight and body mass index on bone mineral density in men and women: The Framingham study
43. Alcohol intake and bone mineral density in elderly men and women: The Framingham Study
44. Long-term bone loss in men: Effects of genetic environmental factors
45. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
46. Effect of thiazide on rates of bone mineral loss: A longitudinal study
47. A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum
48. Reproducibility and validity of a semiquantitative food frequency questionnaire
49. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status
50. Some health benefits of physical activity: The Framingham Study
51. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease
52. Sensitivity and positive predictive value of clinical signs of hypogonadism in elderly men
53. Relationship of serum testosterone to sexual activity in healthy elderly men
54. Ageing of the hypothalamo-pituitary-testicular axis in men
55. Marked decline in trabecular bone mineral content in healthy men with age: Lack of association with sex steroid levels
56. Sex hormones and bone mineral density in elderly men
57. Pathogenesis of vertebral crush fractures in men
58. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?
59. Effects of testosterone supplementation in the aging male
60. Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on markers of bone formation and resorption
61. Effect of testosterone treatment on bone mineral density in men over 65 years of age
62. The effect of an aromatase inhibitor on bone turnover in older men
63. Estradiol formation by human osteoblasts via multiple pathways: Relation with osteoblast function
64. Aromatase expression of human osteoblast-like cells
65. Biology, pharmacology, and clinical applications of androgens: Current status and future prospects